Amylyx Pharmaceuticals, Inc. - AMLX

SEC FilingsOur AMLX Tweets

About Gravity Analytica

Recent News

  • 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.10.2025 - Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock
  • 09.10.2025 - Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock
  • 09.09.2025 - Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock
  • 09.09.2025 - Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock
  • 09.09.2025 - Baird's 2025 Global Healthcare Conference
  • 09.09.2025 - Baird's 2025 Global Healthcare Conference
  • 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference

Recent Filings

  • 09.09.2025 - 424B5 Prospectus [Rule 424(b)(5)]
  • 08.27.2025 - 8-K Current report